| Clinical and biological subtypes of B-cell lymphoma revealed by microenvironmental signatures N Kotlov, A Bagaev, MV Revuelta, JM Phillip, MT Cacciapuoti, ... Cancer discovery 11 (6), 1468-1489, 2021 | 148 | 2021 |
| Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL J Ruan, A Moskowitz, N Mehta-Shah, L Sokol, Z Chen, N Kotlov, G Nos, ... Blood, The Journal of the American Society of Hematology 141 (18), 2194-2205, 2023 | 53* | 2023 |
| High rates of remission with the initial treatment of oral azacitidine plus CHOP for Peripheral T-Cell Lymphoma (PTCL): clinical outcomes and biomarker analysis of a multi … J Ruan, AJ Moskowitz, N Mehta-Shah, L Sokol, Z Chen, R Rahim, W Song, ... Blood 138, 138, 2021 | 6 | 2021 |
| Correlative biomarkers for CART19 response in patients with relapsed or refractory diffuse large B-cell lymphoma CL Batlevi, G Nos, N Kotlov, M Sorokina, M Okwali, A Bagaev, L Michaud, ... Blood 140 (Supplement 1), 9228-9230, 2022 | 1 | 2022 |
| Tumor microenvironment-based methods for assessing car-t and other immunotherapies N Kotlov, G Sagaradze, A Bagaev, G Nos, L Begniagin, D Kravchenko, ... US Patent App. 18/088,184, 2023 | | 2023 |
| Tumor microenvironment-based methods for assessing CAR-T and other immunotherapies N Kotlov, G Sagaradze, A Bagaev, G Nos, L Bedniagin, D Kravchenko, ... US Patent 11,568,959, 2023 | | 2023 |
| Astraea: A first-in-class biomarker database integrating genomic, transcriptomic, and tumor microenvironment properties for precision oncology A Gafurov, I Mamichev, EV Vasileva, GD Sagaradze, MS Shitova, G Nos, ... Cancer Research 81 (13_Supplement), 205-205, 2021 | | 2021 |
